These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2425882)

  • 1. Ventricular size and CSF transmitter metabolite concentrations in severe endogenous depression.
    Standish-Barry HM; Bouras N; Hale AS; Bridges PK; Bartlett JR
    Br J Psychiatry; 1986 Apr; 148():386-92. PubMed ID: 2425882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral transmitter precursors and metabolites in advanced renal disease.
    Sullivan PA; Murnaghan D; Callaghan N; Kantamaneni BD; Curzon G
    J Neurol Neurosurg Psychiatry; 1978 Jul; 41(7):581-8. PubMed ID: 29080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
    Lewine RR; Risch SC; Risby E; Stipetic M; Jewart RD; Eccard M; Caudle J; Pollard W
    Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain transmitter precursors and metabolites in diabetic ketoacidosis.
    Curzon G; Kantamaneni BD; Callaghan N; Sullivan PA
    J Neurol Neurosurg Psychiatry; 1982 Jun; 45(6):489-93. PubMed ID: 6181209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling.
    Geracioti TD; Loosen PT; Ekhator NN; Schmidt D; Chambliss B; Baker DG; Kasckow JW; Richtand NM; Keck PE; Ebert MH
    Depress Anxiety; 1997; 6(3):89-94. PubMed ID: 9442982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression?
    Gjerris A
    Acta Psychiatr Scand Suppl; 1988; 345():21-4. PubMed ID: 2906516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation of plasma free tryptophan and CSF 5-HIAA during migraine.
    Hyypp MT; Kangasniemi P
    Headache; 1977 Mar; 17(1):25-7. PubMed ID: 845024
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.
    Williams WA; Shoaf SE; Hommer D; Rawlings R; Linnoila M
    J Neurochem; 1999 Apr; 72(4):1641-7. PubMed ID: 10098872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
    Wester P; Bergström U; Eriksson A; Gezelius C; Hardy J; Winblad B
    J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
    Banki CM; Molnar G
    Biol Psychiatry; 1981 Aug; 16(8):753-62. PubMed ID: 6169376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report.
    Bryer JB; Starkstein SE; Votypka V; Parikh RM; Price TR; Robinson RG
    J Neuropsychiatry Clin Neurosci; 1992; 4(4):440-2. PubMed ID: 1384852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression.
    Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM
    Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and Parkinson's disease: possible role of serotonergic mechanisms.
    Kostić VS; Djuricić BM; Covicković-Sternić N; Bumbasirević L; Nikolić M; Mrsulja BB
    J Neurol; 1987 Feb; 234(2):94-6. PubMed ID: 2435855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients.
    Curzon G; Kantamaneni BD; Van Boxel P; Gillman PK; Bartlett JR; Bridges PK
    Acta Psychiatr Scand Suppl; 1980; 280():3-20. PubMed ID: 6157303
    [No Abstract]   [Full Text] [Related]  

  • 16. HPLC assays of 5-HIAA and tryptophan in cerebrospinal fluid and 5-HT and tryptophan in blood: a methodological study with clinical applications.
    Larsson M; Forsman A; Hallgren J
    Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):453-60. PubMed ID: 2458513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central neurochemical ultradian variability in depression.
    Salomon RM; Johnson BW; Schmidt DE
    Dis Markers; 2006; 22(1-2):65-72. PubMed ID: 16410652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.
    Sullivan PA; Murnaghan D; Callaghan N; Kantamaneni BD; Curzon G
    J Neurol Neurosurg Psychiatry; 1980 Aug; 43(8):739-43. PubMed ID: 6159456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular enlargement in major depression.
    Scott ML; Golden CJ; Ruedrich SL; Bishop RJ
    Psychiatry Res; 1983 Feb; 8(2):91-3. PubMed ID: 6574534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraspinal pressure influences CSF disposition of tryptophan and 5-HIAA.
    Eklundh T; Nordin C
    Neuropsychobiology; 2001; 44(2):84-7. PubMed ID: 11490176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.